EUVIMEDEUVIMED entdecken
Crossref

Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats

Cristina Campos-Carraro, Patrick Turck, Bruna Gazzi de Lima-Seolin, Rayane Brinck Teixeira, Alexsandra Zimmer, Alex Sander da Rosa Araujo iD, Adriane Belló-Klein iD

Canadian Journal of Physiology and Pharmacology · 2023

DOI: 10.1139/cjpp-2023-0028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2023. Verfasst von Cristina Campos-Carraro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Arterial Hypertension, Oils, Volatile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is involved in increased pulmonary vascular resistance (PVR) and right ventricular (RV) hypertrophy, characteristics of pulmonary arterial hypertension (PAH). Copaiba oil, an antioxidant compound, could attenuate PAH damage. This study’s aim was to determine the effects of copaiba oil on lung oxidative stress, PVR, and mean pulmonary arterial pressure (mPAP) in the monocrotaline (MCT) model of PAH. Male Wistar rats (170 g, n = 7/group) were divided into four groups: control, MCT, copaiba oil, and MCT + copaiba oil (MCT-O). PAH was induced by MCT (60 mg/kg i.p.) and, after 1 week, the treatment with copaiba oil (400 mg/kg/day gavage) was started for 14 days. Echocardiographic and hemodynamic measurements were performed. RV was collected for morphometric evaluations and lungs and the pulmonary artery were used for biochemical analysis. Copaiba oil significantly reduced RV hypertrophy, PVR, mPAP, and antioxidant enzyme activities in the MCT-O group. Moreover, increased nitric oxide synthase and decreased NADPH oxidase activities were observed in the MCT-O group. In conclusion, copaiba oil was able to improve the balance between nitric oxide and reactive oxygen species in lungs and the pulmonary artery and to reduce PVR, which could explain a decrease in RV hypertrophy in this PAH model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryPulmonary Arterial HypertensionOils, VolatileRatsMaleAnimalsRats, WistarMonocrotalineNitric OxideAntioxidantsBiological AvailabilityLungPulmonary ArteryFamilial Primary Pulmonary HypertensionHypertrophy, Right VentricularDisease Models, Animal

Stichwörter der Autor:innen

copaiba oillungsmonocrotalineoxidative stresspulmonary arterial hypertensionpulmonary artery

Substanzen

MonocrotalineNitric OxideAntioxidantsOils, Volatile

Autor:innen und Institutionen

  • Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

ORCID-Profile: Alex Sander da Rosa Araujo, Adriane Belló-Klein

Zitieren

APA

Campos-Carraro, C., Turck, P., de Lima-Seolin, B. G., Teixeira, R. B., Zimmer, A., Araujo, A. S. D. R., & Belló-Klein, A. (2023). Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0028

Vancouver

Campos-Carraro C, Turck P, de Lima-Seolin BG, Teixeira RB, Zimmer A, Araujo ASDR, et al. Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats. Canadian Journal of Physiology and Pharmacology. 2023. doi:10.1139/cjpp-2023-0028

BibTeX
@article{CamposCarraro2023,
  author = {Campos-Carraro, Cristina and Turck, Patrick and de Lima-Seolin, Bruna Gazzi and Teixeira, Rayane Brinck and Zimmer, Alexsandra and Araujo, Alex Sander da Rosa and Belló-Klein, Adriane},
  title = {Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2023},
  doi = {10.1139/cjpp-2023-0028}
}
Kostenlos starten →